BeStock  
Stocks › Biotechnology › LTGO

Latigo Biotherapeutics LTGO

US equityMarket cap rank #3257Biotechnology
$13.00 −$0.24 (-1.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.00 0.00%
Open$13.22
Prev close$13.24
Day range$11.91 – $13.35
Volume267.2K
Market cap$861.89M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$22.93M+7.3% YoY
Net profit-$20.95M+15.5% YoY
Diluted EPS-$0.55+2.4% YoY
Free cash flow-$19.56M+1.8% YoY
Operating cash flow-$19.52M

Revenue, last 7 quarters

$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 7 quarters

$-21.0MMar '25$-25.8MJun '25$-24.8MSep '25$-37.6MDec '25$-23.0MMar '26$-25.8MJun '26$-20.9MSep '26

Diluted EPS by quarter

-0.48Mar '25-0.59Jun '25-0.56Sep '25-0.62Dec '25-0.52Mar '26-0.43Jun '26-0.55Sep '26

Free cash flow by quarter

$-21.3MMar '25$-21.6MJun '25$-19.9MSep '25$-34.9MDec '25$-27.1MMar '26$-21.4MJun '26$-19.6MSep '26

Profitability & balance sheet

Return on equity-27.2%
Return on assets-26.3%
Return on invested capital-28.1%
Current ratio29.11
Liabilities / assets3.5%
Cash & investments$401.24M
Total debt$483,000.00
Net cash (debt)$400.76M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $408.46M $64.76M $50.58M $75.52M $75.52M
-Accounts Payable $5.09M $3.57M $4.46M $5.02M $5.02M
Current Accrued Expenses $4.67M $8.78M $8.63M $8.67M $8.67M
Short-Term Debt and Capital Lease Obligation $705,000.00 $30.60M $502,000.00 $563,000.00 $563,000.00
-Current Capital Lease Obligation $705,000.00 $705,000.00 $502,000.00 $563,000.00 $563,000.00
Total Non-Current Liabilities $518,000.00 $289.27M $288.67M $288.74M $288.74M
Long Term Debt and Capital Lease Obligation $483,000.00 $648,000.00 $52,000.00 $127,000.00 $127,000.00
-Long Term Capital Lease Obligation $483,000.00 $648,000.00 $52,000.00 $127,000.00 $127,000.00
Convertible preferred securities $0.00 $288.58M $288.58M $288.58M $288.58M
Other Non-Current Liabilities $35,000.00 $35,000.00 $35,000.00 $35,000.00 $35,000.00
Total Equity $393.97M -$276.08M -$252.58M -$231.67M -$231.67M
Payables $5.09M $3.57M $4.46M $5.02M $5.02M
Total Current Liabilities $13.96M $51.58M $14.49M $18.45M $18.45M
Total Liabilities $14.48M $340.84M $303.16M $307.19M $307.19M
Total Current Assets $406.44M $59.20M $46.84M $73.83M $73.83M
Cash and Cash Equivalents & Short-Term Investments $401.24M $55.00M $42.18M $69.44M $69.44M
-Cash and Cash Equivalents $401.24M $55.00M $42.18M $69.44M $69.44M
Prepaid Assets $5.03M $4.00M $4.47M $4.20M $4.20M
Restricted Cash $168,000.00 $194,000.00 $192,000.00 $192,000.00 $192,000.00
Total Non-Current Assets $2.01M $5.56M $3.74M $1.69M $1.69M
Net PPE $1.58M $1.76M $900,000.00 $1.07M $1.07M
-Gross PPE $2.59M $2.71M $1.80M $1.93M $1.93M
-Accumulated Depreciation -$1.01M -$953,000.00 -$901,000.00 -$854,000.00 -$854,000.00
Other Non-Current Assets $433,000.00 $3.80M $2.84M $616,000.00 $616,000.00
Stockholders' Equity $393.97M -$276.08M -$252.58M -$231.67M -$231.67M
Capital Stock $7,000.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $7,000.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $706.81M $15.81M $13.51M $11.46M $11.46M
Retained Earnings -$312.84M -$291.89M -$266.09M -$243.13M -$243.13M
Other Current Liabilities – $5.15M – – –
-Current Debt – $29.90M – – –

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Special Income (Charges) -$4.58M – – – –
Gain on Sale of Security $5.15M – – – –
Other Income (Expense) $553,000.00 -$2,000.00 $1,000.00 -$1.72M -$2,000.00
Non-Operating Interest Expense $699,000.00 $251,000.00 – – –
Non-Operating Interest Income $2.13M $264,000.00 $474,000.00 $2.94M $830,000.00
Net Non-Operating Interest Income (Expense) $1.43M $13,000.00 $474,000.00 $2.94M $830,000.00
Operating Profit -$22.93M -$25.81M -$23.44M -$110.39M -$38.41M
Research & Development $17.50M $21.23M $17.63M $99.53M $35.82M
-General & Admin Expense $5.43M $4.58M $5.80M $10.86M $2.59M
Operating Expense $22.93M $25.81M $23.44M $110.39M $38.41M
-Less:Other Special Charges $4.58M – – – –
Other Non-Operating Income (Expenses) -$14,000.00 -$2,000.00 $1,000.00 -$1.72M -$2,000.00
Pretax Profit -$20.95M -$25.80M -$22.96M -$109.17M -$37.58M
Diluted EPS -$0.55 -$0.43 -$0.52 -$2.48 -$0.62
Basic EPS -$0.55 -$0.43 -$0.52 -$2.48 -$0.62
Net Income to Common Stockholders -$20.95M -$25.80M -$22.96M -$109.17M -$37.58M
Net Income to Parent Company -$20.95M -$25.80M -$22.96M -$109.17M -$37.58M
Profit from Continuing Operations -$20.95M -$25.80M -$22.96M -$109.17M -$37.58M
Net Profit -$20.95M -$25.80M -$22.96M -$109.17M -$37.58M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Selling and Admin Expenses $5.43M $4.58M $5.80M $10.86M $2.59M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Operating Cash Flow -$19.52M -$21.28M -$27.07M -$34.93M -$97.56M
Beginning Cash Balance $55.21M $42.42M $69.72M $104.64M $17.92M
Net PPE Purchase and Sale -$36,000.00 -$110,000.00 $0.00 -$1,000.00 -$136,000.00
Financing Cash Flow $365.76M $34.18M -$230,000.00 $9,000.00 $149.50M
Net Cash Flow from Continuing Financing Activities $365.76M $34.18M -$230,000.00 $9,000.00 $149.50M
Net Issuance Payments Of Debt -$168,000.00 – – – –
Net Preferred Stock Issuance $0.00 $0.00 $0.00 $0.00 $149.38M
Proceeds from Stock Option Exercised $265,000.00 $153,000.00 $78,000.00 $9,000.00 $117,000.00
Ending Cash Balance $401.41M $55.21M $42.42M $69.72M $69.72M
Net Change in Cash $346.20M $12.79M -$27.30M -$34.92M $51.80M
Net Cash Flow from Continuing Investing Activities -$36,000.00 -$110,000.00 $0.00 -$1,000.00 -$136,000.00
Free Cash Flow -$19.56M -$21.39M -$27.07M -$34.93M -$97.69M
Net cash flow from continuing operations -$19.52M -$21.28M -$27.07M -$34.93M -$97.56M
Net cash flow from investing -$36,000.00 -$110,000.00 $0.00 -$1,000.00 -$136,000.00
Net Income from Continuing Operations -$20.95M -$25.80M -$22.96M -$37.58M -$109.17M
Depreciation & Depletion & Amortization $53,000.00 $52,000.00 $47,000.00 $49,000.00 $249,000.00
Change in Working Capital -$1.46M $1.89M -$6.26M $739,000.00 $2.52M
-Change in Prepaid Assets -$1.03M $472,000.00 -$274,000.00 $796,000.00 -$979,000.00
Other Non-Cash Items $861,000.00 $432,000.00 $124,000.00 $121,000.00 $444,000.00
-Change in Other Current Liabilities -$165,000.00 -$160,000.00 -$136,000.00 -$132,000.00 -$446,000.00
-Change in Other Current Assets $3.35M -$1.00M -$2.26M -$500,000.00 -$234,000.00
-Change in Payables and Accrued Expense -$3.62M $2.58M -$3.59M $575,000.00 $4.18M
Net Other Financing Charges – -$974,000.00 -$308,000.00 – –
Net Common Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on LTGO.

Sign in to join the discussion.

Scroll to Top